Exploring synergy and its role in antimicrobial peptide biology

Methods Enzymol. 2022:663:99-130. doi: 10.1016/bs.mie.2021.09.017. Epub 2021 Oct 27.

Abstract

Antimicrobial peptides will be an essential component in combating the escalating issue of antibiotic resistance. Identifying synergistic combinations of two or more substances will increase the value of these peptides further. Several potential pitfalls in conducting synergy testing with peptides are discussed in detail. As case studies, we describe observations of AMP synergy with peptides, antibiotics, and metal ions as well as some of the mechanistic details that have been uncovered. The Bliss and Loewe models for synergy are presented prior to recommending protocols for conducting checkerboard, minimal inhibitory concentration, and time-kill assays. Establishing mechanisms of action and exploring the potential for resistance will be crucial to translate these studies into the clinic.

Keywords: AMPs; Bliss; Checkerboard assay; FIC; Loewe; Resistance; Synergy.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Antimicrobial Peptides*
  • Biology
  • Drug Synergism
  • Microbial Sensitivity Tests

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Peptides